Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Tiberi

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
The European Respiratory Journal|June 12, 2016
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquilineMarina Tadolini, Rangjung Dolma Lingtsang, Simon Tiberi, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|May 1, 2019
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitationSimon Tiberi, Marcela Muñoz Torrico, Ananna Rahman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 28, 2022
Drug resistant TB - latest developments in epidemiology, diagnostics and managementSimon Tiberi, Natasa Utjesanovic, Jessica Galvin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2010
Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trialAlessandro Soria, Anna Danise, Laura Galli, et al.
Journal of Critical Care|March 24, 2018
The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection controlAkaninyene Otu, Madiha Hashmi, Ahmed M Mukhtar, et al.
The Journal of Infection|June 25, 2020
Extraspinal articular tuberculosis: An 11-year retrospective study of demographic features and clinical outcomes in East LondonEmma McGuire, Swathi Rajagopal, Trishan Vaikunthanathan, et al.
The European Respiratory Journal|November 21, 2015
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experienceSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2020
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patientsOnno W Akkerman, Lies Ter Beek, Rosella Centis, et al.
Presse Medicale (Paris, France : 1983)|February 6, 2022
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosisGiovanni Battista Migliori, Jose' Caminero Luna, Xhevat Kurhasani, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2022
The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazidVanessa B Vogensen, Richard M Anthony, Huib A M Kerstjens, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
The European Respiratory Journal|June 12, 2016
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquilineMarina Tadolini, Rangjung Dolma Lingtsang, Simon Tiberi, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|May 1, 2019
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitationSimon Tiberi, Marcela Muñoz Torrico, Ananna Rahman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 28, 2022
Drug resistant TB - latest developments in epidemiology, diagnostics and managementSimon Tiberi, Natasa Utjesanovic, Jessica Galvin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2010
Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trialAlessandro Soria, Anna Danise, Laura Galli, et al.
Journal of Critical Care|March 24, 2018
The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection controlAkaninyene Otu, Madiha Hashmi, Ahmed M Mukhtar, et al.
The Journal of Infection|June 25, 2020
Extraspinal articular tuberculosis: An 11-year retrospective study of demographic features and clinical outcomes in East LondonEmma McGuire, Swathi Rajagopal, Trishan Vaikunthanathan, et al.
The European Respiratory Journal|November 21, 2015
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experienceSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2020
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patientsOnno W Akkerman, Lies Ter Beek, Rosella Centis, et al.
Presse Medicale (Paris, France : 1983)|February 6, 2022
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosisGiovanni Battista Migliori, Jose' Caminero Luna, Xhevat Kurhasani, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2022
The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazidVanessa B Vogensen, Richard M Anthony, Huib A M Kerstjens, et al.
Pageof 15